Brandon Busbee, MD
Retina Specialist · Nashville, TNNPI 1609952654
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $440,199 of the $566,104 with a category attached, or 77.8%. Thea Pharma Inc. accounts for 77.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $228,940 and has fallen 92.6% since, to $17,048 in 2025. Among retina specialist clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $2933.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Thea Pharma Inc.$440K
- Apellis Pharmaceuticals, Inc.$60K
- US Retina LLC$34K
- Genentech USA, Inc.$18K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$11K
- AbbVie$2K
- plus $1K from 14 others
Across 146 payments — averaging $8025.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$953K
- Eyepoint US, Inc.$201K
- Regeneron$18K
What the payments were for
- Royalty or licence$440,19978%
- Consulting fees$22,7854%
- Speaking & faculty fees$52,8489%
- Travel & lodging$10,9092%
- Food & beverage$5,8351%
- Ownership interest$14,5233%
- Other$19,0053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Thea Pharma Inc. | 11 | $440,199 |
| Apellis Pharmaceuticals, Inc. | 53 | $60,181 |
| US Retina LLC | 7 | $33,528 |
| Genentech USA, Inc. | 44 | $18,077 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 20 | $10,834 |
| AbbVie(2 entities) | 14 | $1,831 |
| Astellas Pharma US Inc | 17 | $493 |
| Regeneron Healthcare Solutions, Inc. | 6 | $214 |
| Dutch Ophthalmic, USA | 1 | $140 |
| Neurotech Pharmaceuticals, Inc. | 1 | $125 |
| Biogen | 4 | $95 |
| Bausch & Lomb Americas Inc. | 1 | $83 |
| Iridex Corporation | 1 | $65 |
| Coherus Oncology, Inc. | 3 | $63 |
| Novartis | 3 | $48 |
| Eyepoint US, Inc. | 3 | $46 |
| Regeneron | 1 | $23 |
| Alcon | 1 | $22 |
| Alimera Sciences, Inc. | 1 | $22 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AKTEN$440,199
- Syfovre$58,106
- VABYSMO$10,034
- OPHTHALMIC INSTRUMENTS$7,468
- Lucentis$7,439
- VITESSE$2,968
- OZURDEX$1,500
- EVA, combined machine$140
- TISSUEBLUE$140
- EYLEA HD$105
- STELLARIS PC$104
- Izervay$101
How this compares
$566,104 in reported general payments places this provider in the 90th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 17 | $2,888 |
| Prednisolone Acetate | 53 | $2,512 |
| Brimonidine Tartrate | 11 | $2,395 |
| Eplerenone | 13 | $1,833 |
| Ketorolac Tromethamine | 43 | $1,125 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 80 | $976 |
| Latanoprost | 40 | $398 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $318 |
| Ciprofloxacin Hcl | 15 | $193 |
| Timolol Maleate | 12 | $88 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Nashville
- Carl AwhNashville$1.3M
- Peter SonkinNashville$949K
- Eric SchneiderNashville$134K
- David ReichsteinNashville$114K
- Akshay ThomasNashville$108K
- Franco RecchiaNashville$72K
- Everton ArrindellNashville$39K
- Roy WallaceNashville$19K
- Kenneth MoffatNashville$17K
- Brigid MarshallNashville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.